Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesDiseases and Disorders of the Nervous SystemDRG 093-other-disorders-of-nervous-system-without-cc-mcc
    Ask Trek AI about this page

    Other Disorders of Nervous System without CC/MCC: Inpatient Reimbursement Overview

    DRG 093 encompasses noncomplicated inpatient nervous system disorders that lack Major Complications or Comorbidities and Complications or Comorbidities, defining a lower-acuity payment tier. It matters for inpatient reimbursement because the Diagnosis-Related Group assignment drives the Centers for Medicare & Medicaid Services prospective payment amount and reflects expected resource use for these neurologic cases.

    Customize your policy alerts

    Sign up for drg 093 policy alerts

    Get alerted when payer policies referencing 093 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 093 Overview

    DRG 093 covers inpatient admissions for a variety of nervous system disorders that do not include a Major Complication or Comorbidity or a Complication or Comorbidity. Typical cases include noncomplex presentations of neuropathies, nonacute movement disorders, and other neurologic conditions managed without major complications. This Diagnosis-Related Group matters for Medicare payment because it groups clinically similar resource use and determines the standardized prospective payment for hospitals under Centers for Medicare & Medicaid Services rules. Accurate coding and documentation of the principal diagnosis and any comorbid conditions influence assignment to this Diagnosis-Related Group and the associated reimbursement level.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Acute inpatient intervention trials evaluating short-term neuroprotective or symptom-control strategies for non-traumatic, non-infectious nervous system conditions (for example acute exacerbations of demyelinating disease, seizure clusters, or acute movement disorder decompensation). These studies enroll hospitalized adults presenting with sudden worsening of neurologic symptoms to assess interventions delivered during the index admission, measuring endpoints such as time to symptom control, length of stay, need for ICU-level care, and in-hospital complications. Results inform providers about immediate efficacy and safety in the acute care setting and help payers model expected resource use and costs tied to successful early interventions.
    • Comparative effectiveness studies of diagnostic pathways and inpatient management strategies for heterogeneous, non-CC/MCC neurologic disorders (for example comparing advanced neuroimaging and electrophysiology-guided workups versus standard evaluations for episodic neurologic complaints). These trials typically recruit patients admitted with unexplained focal deficits, complex headaches, or suspected functional neurologic presentations to determine which diagnostic algorithms reduce unnecessary tests, shorten hospital stays, and improve diagnostic yield. Findings are relevant to hospital clinicians and payers because they can guide care pathways that optimize appropriate use of resources while reducing avoidable admissions or repeat visits.
    • Post-discharge outcomes and care-transition research focusing on rehabilitation needs, readmission prevention, and outpatient follow-up for patients discharged after treatment for non-major nervous system disorders. These cohort or pragmatic trials follow patients after discharge to evaluate interventions such as structured outpatient neurology follow-up, telehealth monitoring of symptom relapse, or tailored rehabilitation plans, with endpoints including 30- and 90-day readmissions, functional recovery, and patient-reported outcomes. Such research helps providers identify which transitional care models improve recovery and helps payers predict downstream utilization and support value-based care strategies.

    Related Codes

    020-INTRACRANIAL-VASCULAR-PROCEDURES-WITH-PRINCIPAL-DIAGNOSIS-HEMORRHAGE-WITH-MCC

    Intracranial Vascular Procedures with Principal Diagnosis Hemorrhage with MCC: Inpatient Reimbursement Overview

    021-INTRACRANIAL-VASCULAR-PROCEDURES-WITH-PRINCIPAL-DIAGNOSIS-HEMORRHAGE-WITH-CC

    Intracranial Vascular Procedures with Principal Diagnosis Hemorrhage with CC: Inpatient Reimbursement Overview

    022-INTRACRANIAL-VASCULAR-PROCEDURES-WITH-PRINCIPAL-DIAGNOSIS-HEMORRHAGE-WITHOUT-CC-MCC

    Intracranial Vascular Procedures with Principal Diagnosis Hemorrhage without CC/MCC: Inpatient Reimbursement Overview

    023-CRANIOTOMY-WITH-MAJOR-DEVICE-IMPLANT-OR-ACUTE-COMPLEX-CNS-PRINCIPAL-DIAGNOSIS-WITH-MCC-OR-ANTINEOPLASTIC-IMPLANT-OR-EPILEPSY-WITH-NEUROSTIMULATOR

    Craniotomy with Major Device Implant or Complex CNS DRG 023: Inpatient Reimbursement Overview

    024-CRANIOTOMY-WITH-MAJOR-DEVICE-IMPLANT-OR-ACUTE-COMPLEX-CNS-PRINCIPAL-DIAGNOSIS-WITHOUT-MCC

    Craniotomy with Major Device Implant or Acute Complex CNS Principal Diagnosis without MCC: Inpatient Reimbursement Overview

    025-CRANIOTOMY-AND-ENDOVASCULAR-INTRACRANIAL-PROCEDURES-WITH-MCC

    Craniotomy and Endovascular Intracranial Procedures with MCC: Inpatient Reimbursement Overview

    026-CRANIOTOMY-AND-ENDOVASCULAR-INTRACRANIAL-PROCEDURES-WITH-CC

    Craniotomy and Endovascular Intracranial Procedures with CC: Inpatient Reimbursement Overview

    027-CRANIOTOMY-AND-ENDOVASCULAR-INTRACRANIAL-PROCEDURES-WITHOUT-CC-MCC

    Craniotomy and Endovascular Intracranial Procedures without CC/MCC: Inpatient Reimbursement Overview

    028-SPINAL-PROCEDURES-WITH-MCC

    Spinal Procedures with MCC: Inpatient Reimbursement Overview

    029-SPINAL-PROCEDURES-WITH-CC-OR-SPINAL-NEUROSTIMULATORS

    Spinal Procedures with CC or Spinal Neurostimulators: Inpatient Reimbursement Overview

    Showing 1–10 of 71

    • More pages

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.